Homocysteine, Alzheimer's disease, and cognitive function

Nutrition

Volumn 16, Issue 7-8, 2000, Pages 675-677

  Miller, Joshua W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

AGED; ALZHEIMER DISEASE; CARDIOVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; HUMAN; HYPERHOMOCYSTEINEMIA; PATHOGENESIS; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; COGNITION; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; VASCULAR DISEASES;

EID: 0034234789     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(00)00307-5     Document Type: Conference Paper

References (32)

1. United Nations General Assembly. Proclamation on Ageing. Resolution 47/ 1998:5.
2. Bush G. Presidential Proclamation 1990:6158.
3. World population prospects. Sex and age. 1998;United Nations Publications, New York, NY.
4. Evans D.A., Funkenstein H.H., Albert M.S., et al. Prevalence of Alzheimer's disease in a community population of older persons higher than previously reported . JAMA. 262:1989;2551.
5. Schenk D., Barbour R., Dunn W., et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400:1999;173.
6. Kandel ER, Schwartz JH, Jessell TM. Principles of Neuroscience, 3rd ed. Norwalk, CO: Appleton + Lange, 1991.
7. Hofman A., Ott A., Breteler M.M.B., et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 349:1997;151.
8. Buée L., Hof P.R., Bouras C., et al. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol. 87:1994;469.
9. Launer L.J., Masaki K., Petrovich H., et al. The association between midlife blood pressure levels and late-life cognitive function the Honolulu-Asia Aging Study . JAMA. 274:1995;1846.
10. Roses A.D. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med. 47:1996;387.
11. Haan M.N., Shemanski L., Jagust W.J., Manolio T.A., Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA. 282:1999;40.
12. Snowden D.A., Greiner L.H., Mortimer J.A., et al. Brain infarction and the clinical expression of Alzheimer disease the Nun Study . JAMA. 277:1997;813.
13. Refsum H., Ueland P.M., Nygard O., et al. Homocysteine and cardiovascular disease. Annu Rev Med. 49:1998;31.
14. Clarke R., Smith A.D., Jobst K.A., et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol. 55:1998;1449.
15. Miller J.W. Homocysteine and Alzheimer's disease. Nutr Rev. 57:1999;126.
16. Bell I.R., Edman J.S., Selhub J., et al. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand. 86:1992;386.
17. Riggs K.M., Spiro A., Tucker K., Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr. 63:1996;306.
18. McCaddon A., Davies G., Hudson P., et al. Total serum homocysteine in senile dementia of the Alzheimer's type. Int J Geriatr Psychiatry. 13:1998;235.
19. Blijhan G.H. Homocysteine metabolism 2nd international conference. Neth J Med. 52:(suppl):1998;S1.
20. Miller J.W., Green R., Allen L.H., Mungas D.M., Haan M.N. Homocysteine correlates with cognitive function in the Sacramento Area Latino Study of Aging (SALSA). FASEB J. 13:1999;A374.
21. Folstein M.F., Folstein F.E., McHugh P.R. Mini-mental state a practical method for grading the cognitive state of patients for the clinician . J Psychiatr Res. 12:1975;189.
22. Kalmijn S., Launer L.J., Lindemans J., et al. Total homocysteine and cognitive decline in a community-based sample of elderly subjects the Rotterdam Study . Am J Epidemiol. 150:1999;283.
23. Selhub J., Jacques P.F., Wilson P.W.F., Rush D., Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 270:1993;2693.
24. Jacques P.F., Selhub J., Bostom A.G., Wilson P.W., Rosenberg I.H. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med. 340:1999;1449.
25. Lawrence J.M., Petitti D.B., Watkins M., Umekubo M.A. Trends in serum folate after food fortification. Lancet. 354:1999;915.
26. Green R., Miller J.W. Folate deficiency beyond megaloblastic anemia hyperhomocysteinemia and other manifestations of dysfunctional folate metabolism . Semin Hematol. 36:1999;47.
27. Chanarin I. The Megaloblastic Anemias, 2nd ed. Oxford: Blackwell Scientific Publications, 1979.
28. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med. 156:1996;1097.
29. Carmel R., Sinow R.M., Siegel M.E., et al. Food cobalamin malabsorption occurs frequently in patients with unexplained low serum cobalamin levels. Arch Int Med. 148:1988;1715.
30. Pennypacker L., Allen R.H., Kelly J.P., et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc. 39:1991;1155.
31. Kuzminski A.M., Del Giacco E.J., Allen R.H., Stabler S.P., Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood. 92:1998;1191.
32. 12 status. FASEB J. 13:1999;A936.